Total number of protein in "GO:0002699" GO term: 219
Identifier | UniProt Gene | UniProt Accession | UniProt Name | Chromosome | GO term | Database | Cancer Driver | Number of missense mutations | Missense mutation per residues | Number of disordered residues | Number of mutations in disordered regions | Disordered missense mutations per residues | Number of OMIM mutation |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
ADGRE2 | ADGRE2 | Q9UHX3 | Adhesion G protein-coupled receptor E2 | chr19 | GO:0002699 | Not Cancer Driver | No | 134 | 0.163 | 104 | 22 | 0.212 | 1 |
ADORA2B | ADORA2B | P29275 | Adenosine receptor A2b | chr17 | GO:0002699 | Not Cancer Driver | No | 23 | 0.069 | 0 | 0 | 0.0 | 0 |
ANKRD17 | ANKRD17 | O75179 | Ankyrin repeat domain-containing protein 17 | chr4 | GO:0002699 | Not Cancer Driver | No | 312 | 0.12 | 1790 | 221 | 0.123 | 9 |
ANXA1_ENST00000257497 | ANXA1 | P04083 | Annexin A1 | chr9 | GO:0002699 | Not Cancer Driver | No | 59 | 0.171 | 61 | 12 | 0.197 | 0 |
AP1G1_ENST00000569748 | AP1G1 | O43747 | AP-1 complex subunit gamma-1 | chr16 | GO:0002699 | Not Cancer Driver | No | 111 | 0.135 | 144 | 22 | 0.153 | 0 |
APPL2_ENST00000258530 | APPL2 | Q8NEU8 | DCC-interacting protein 13-beta | chr12 | GO:0002699 | Not Cancer Driver | No | 70 | 0.105 | 149 | 14 | 0.094 | 0 |
ARG1_ENST00000368087 | ARG1 | P05089 | Arginase-1 | chr6 | GO:0002699 | Not Cancer Driver | No | 41 | 0.127 | 83 | 12 | 0.145 | 9 |
ARID5A | ARID5A | Q03989 | AT-rich interactive domain-containing protein 5A | chr2 | GO:0002699 | Not Cancer Driver | No | 64 | 0.108 | 373 | 42 | 0.113 | 0 |
ATAD5 | ATAD5 | Q96QE3 | ATPase family AAA domain-containing protein 5 | chr17 | GO:0002699 | Not Cancer Driver | No | 200 | 0.108 | 1075 | 112 | 0.104 | 0 |
AZGP1 | AZGP1 | P25311 | Zinc-alpha-2-glycoprotein | chr7 | GO:0002699 | Not Cancer Driver | No | 59 | 0.198 | 41 | 10 | 0.244 | 0 |
B2M | B2M | P61769 | Beta-2-microglobulin | chr15 | GO:0002699 | Census, Compendium | Yes | 34 | 0.286 | 5 | 1 | 0.2 | 2 |
BCL10 | BCL10 | O95999 | B-cell lymphoma/leukemia 10 | chr1 | GO:0002699 | Census, Compendium | Yes | 36 | 0.155 | 151 | 25 | 0.166 | 0 |
BLK | BLK | P51451 | Tyrosine-protein kinase Blk | chr8 | GO:0002699 | Not Cancer Driver | No | 94 | 0.186 | 75 | 21 | 0.28 | 0 |
BTK_ENST00000308731 | BTK | Q06187 | Tyrosine-protein kinase BTK | chrX | GO:0002699 | Census, Compendium | Yes | 147 | 0.223 | 114 | 27 | 0.237 | 110 |
C12orf4 | C12orf4 | Q9NQ89 | Protein C12orf4 | chr12 | GO:0002699 | Not Cancer Driver | No | 70 | 0.127 | 111 | 8 | 0.072 | 1 |
C17orf99 | C17orf99 | Q6UX52 | Protein IL-40 | chr17 | GO:0002699 | Not Cancer Driver | No | 16 | 0.06 | 84 | 3 | 0.036 | 0 |
C3 | C3 | P01024 | Complement C3 | chr19 | GO:0002699 | Not Cancer Driver | No | 337 | 0.203 | 287 | 50 | 0.174 | 12 |
CADM1_ENST00000452722 | CADM1 | Q9BY67 | Cell adhesion molecule 1 | chr11 | GO:0002699 | Not Cancer Driver | No | 106 | 0.24 | 103 | 28 | 0.272 | 0 |
CAMK4_ENST00000512453 | CAMK4 | Q16566 | Calcium/calmodulin-dependent protein kinase type IV | chr5 | GO:0002699 | Not Cancer Driver | No | 101 | 0.214 | 127 | 30 | 0.236 | 0 |
CCL19 | CCL19 | Q99731 | C-C motif chemokine 19 | chr9 | GO:0002699 | Not Cancer Driver | No | 10 | 0.102 | 7 | 0 | 0.0 | 0 |
CCR2_ENST00000400888 | CCR2 | P41597 | C-C chemokine receptor type 2 | chr3 | GO:0002699 | Not Cancer Driver | No | 81 | 0.217 | 23 | 1 | 0.043 | 0 |
CD160_ENST00000369288 | CD160 | O95971 | CD160 antigen | chr1 | GO:0002699 | Not Cancer Driver | No | 20 | 0.11 | 2 | 0 | 0.0 | 0 |
CD177 | CD177 | Q8N6Q3 | CD177 antigen | chr19 | GO:0002699 | Not Cancer Driver | No | 71 | 0.162 | 79 | 26 | 0.329 | 0 |
CD1A | CD1A | P06126 | T-cell surface glycoprotein CD1a | chr1 | GO:0002699 | Not Cancer Driver | No | 105 | 0.321 | 18 | 6 | 0.333 | 0 |
CD1B | CD1B | P29016 | T-cell surface glycoprotein CD1b | chr1 | GO:0002699 | Not Cancer Driver | No | 97 | 0.291 | 7 | 0 | 0.0 | 0 |
CD1C | CD1C | P29017 | T-cell surface glycoprotein CD1c | chr1 | GO:0002699 | Not Cancer Driver | No | 127 | 0.381 | 1 | 0 | 0.0 | 0 |
CD1D | CD1D | P15813 | Antigen-presenting glycoprotein CD1d | chr1 | GO:0002699 | Not Cancer Driver | No | 93 | 0.278 | 19 | 7 | 0.368 | 0 |
CD1E | CD1E | P15812 | T-cell surface glycoprotein CD1e, membrane-associated | chr1 | GO:0002699 | Not Cancer Driver | No | 158 | 0.407 | 21 | 11 | 0.524 | 0 |
CD226_ENST00000582621 | CD226 | Q15762 | CD226 antigen | chr18 | GO:0002699 | Not Cancer Driver | No | 79 | 0.235 | 47 | 11 | 0.234 | 0 |
CD244 | CD244 | Q9BZW8 | Natural killer cell receptor 2B4 | chr1 | GO:0002699 | Not Cancer Driver | No | 77 | 0.208 | 92 | 22 | 0.239 | 0 |
CD28 | CD28 | P10747 | T-cell-specific surface glycoprotein CD28 | chr2 | GO:0002699 | Census | Yes | 42 | 0.191 | 18 | 10 | 0.556 | 0 |
CD300A | CD300A | Q9UGN4 | CMRF35-like molecule 8 | chr17 | GO:0002699 | Not Cancer Driver | No | 53 | 0.177 | 70 | 10 | 0.143 | 0 |
CD36_ENST00000309881 | CD36 | P16671 | Platelet glycoprotein 4 | chr7 | GO:0002699 | Not Cancer Driver | No | 75 | 0.159 | 12 | 3 | 0.25 | 3 |
CD40 | CD40 | P25942 | Tumor necrosis factor receptor superfamily member 5 | chr20 | GO:0002699 | Not Cancer Driver | No | 39 | 0.141 | 56 | 6 | 0.107 | 2 |
CD46_ENST00000358170 | CD46 | P15529 | Membrane cofactor protein | chr1 | GO:0002699 | Not Cancer Driver | No | 53 | 0.135 | 52 | 4 | 0.077 | 5 |
CD55_ENST00000367064 | CD55 | P08174 | Complement decay-accelerating factor | chr1 | GO:0002699 | Not Cancer Driver | No | 45 | 0.118 | 128 | 13 | 0.102 | 1 |
CD74 | CD74 | P04233 | HLA class II histocompatibility antigen gamma chain | chr5 | GO:0002699 | Census | Yes | 31 | 0.105 | 185 | 20 | 0.108 | 0 |
CD80_ENST00000478182 | CD80 | P33681 | T-lymphocyte activation antigen CD80 | chr3 | GO:0002699 | Not Cancer Driver | No | 50 | 0.174 | 26 | 5 | 0.192 | 0 |
CD81 | CD81 | P60033 | CD81 antigen | chr11 | GO:0002699 | Not Cancer Driver | No | 28 | 0.119 | 0 | 0 | 0.0 | 0 |
CD84 | CD84 | Q9UIB8 | SLAM family member 5 | chr1 | GO:0002699 | Not Cancer Driver | No | 82 | 0.238 | 52 | 11 | 0.212 | 0 |
CD86 | CD86 | P42081 | T-lymphocyte activation antigen CD86 | chr3 | GO:0002699 | Not Cancer Driver | No | 90 | 0.274 | 56 | 18 | 0.321 | 0 |
CLCF1 | CLCF1 | Q9UBD9 | Cardiotrophin-like cytokine factor 1 | chr11 | GO:0002699 | Not Cancer Driver | No | 22 | 0.098 | 42 | 4 | 0.095 | 1 |
CLEC7A | CLEC7A | Q9BXN2 | C-type lectin domain family 7 member A | chr12 | GO:0002699 | Not Cancer Driver | No | 43 | 0.174 | 46 | 2 | 0.043 | 0 |
CLNK | CLNK | Q7Z7G1 | Cytokine-dependent hematopoietic cell linker | chr4 | GO:0002699 | Not Cancer Driver | No | 85 | 0.199 | 320 | 73 | 0.228 | 0 |
COLEC10 | COLEC10 | Q9Y6Z7 | Collectin-10 | chr8 | GO:0002699 | Not Cancer Driver | No | 58 | 0.209 | 95 | 23 | 0.242 | 1 |
COLEC11_ENST00000349077 | COLEC11 | Q9BWP8 | Collectin-11 | chr2 | GO:0002699 | Not Cancer Driver | No | 72 | 0.266 | 158 | 40 | 0.253 | 2 |
CR1_ENST00000367053 | CR1 | P17927 | Complement receptor type 1 | chr1 | GO:0002699 | Compendium | Yes | 383 | 0.188 | 151 | 42 | 0.278 | 0 |
CRTAM | CRTAM | O95727 | Cytotoxic and regulatory T-cell molecule | chr11 | GO:0002699 | Not Cancer Driver | No | 64 | 0.163 | 135 | 14 | 0.104 | 0 |
DDX1 | DDX1 | Q92499 | ATP-dependent RNA helicase DDX1 | chr2 | GO:0002699 | Not Cancer Driver | No | 82 | 0.111 | 91 | 15 | 0.165 | 0 |
DDX21 | DDX21 | Q9NR30 | Nucleolar RNA helicase 2 | chr10 | GO:0002699 | Not Cancer Driver | No | 72 | 0.092 | 342 | 30 | 0.088 | 0 |
DDX58 | DDX58 | O95786 | Antiviral innate immune response receptor RIG-I | chr9 | GO:0002699 | Not Cancer Driver | No | 118 | 0.128 | 61 | 10 | 0.164 | 2 |
DDX60 | DDX60 | Q8IY21 | Probable ATP-dependent RNA helicase DDX60 | chr4 | GO:0002699 | Not Cancer Driver | No | 224 | 0.131 | 131 | 12 | 0.092 | 0 |
DENND1B | DENND1B | Q6P3S1 | DENN domain-containing protein 1B | chr1 | GO:0002699 | Not Cancer Driver | No | 69 | 0.089 | 299 | 19 | 0.064 | 0 |
DHX36 | DHX36 | Q9H2U1 | ATP-dependent DNA/RNA helicase DHX36 | chr3 | GO:0002699 | Not Cancer Driver | No | 159 | 0.158 | 222 | 39 | 0.176 | 0 |
DHX58 | DHX58 | Q96C10 | ATP-dependent RNA helicase DHX58 | chr17 | GO:0002699 | Not Cancer Driver | No | 62 | 0.091 | 84 | 8 | 0.095 | 0 |
ENPP3_ENST00000357639 | ENPP3 | O14638 | Ectonucleotide pyrophosphatase/phosphodiesterase family member 3 | chr6 | GO:0002699 | Not Cancer Driver | No | 146 | 0.167 | 57 | 12 | 0.211 | 0 |
EXOSC3 | EXOSC3 | Q9NQT5 | Exosome complex component RRP40 | chr9 | GO:0002699 | Not Cancer Driver | No | 18 | 0.065 | 54 | 2 | 0.037 | 4 |
EXOSC6 | EXOSC6 | Q5RKV6 | Exosome complex component MTR3 | chr16 | GO:0002699 | Not Cancer Driver | No | 3 | 0.011 | 102 | 0 | 0.0 | 0 |
F2RL1 | F2RL1 | P55085 | Proteinase-activated receptor 2 | chr5 | GO:0002699 | Not Cancer Driver | No | 55 | 0.139 | 7 | 2 | 0.286 | 0 |
FADD | FADD | Q13158 | FAS-associated death domain protein | chr11 | GO:0002699 | Not Cancer Driver | No | 26 | 0.125 | 45 | 10 | 0.222 | 1 |
FAM49B_ENST00000519540 | CYRIB | Q9NUQ9 | CYFIP-related Rac1 interactor B | chr8 | GO:0002699 | Not Cancer Driver | No | 53 | 0.164 | 78 | 11 | 0.141 | 0 |
FBXO38_ENST00000340253 | FBXO38 | Q6PIJ6 | F-box only protein 38 | chr5 | GO:0002699 | Not Cancer Driver | No | 133 | 0.112 | 440 | 48 | 0.109 | 1 |
FCER2 | FCER2 | P06734 | Low affinity immunoglobulin epsilon Fc receptor | chr19 | GO:0002699 | Not Cancer Driver | No | 41 | 0.128 | 130 | 22 | 0.169 | 0 |
FCN1 | FCN1 | O00602 | Ficolin-1 | chr9 | GO:0002699 | Not Cancer Driver | No | 107 | 0.328 | 88 | 15 | 0.17 | 0 |
FCN2 | FCN2 | Q15485 | Ficolin-2 | chr9 | GO:0002699 | Not Cancer Driver | No | 73 | 0.233 | 80 | 19 | 0.237 | 0 |
FCN3 | FCN3 | O75636 | Ficolin-3 | chr1 | GO:0002699 | Not Cancer Driver | No | 46 | 0.154 | 65 | 19 | 0.292 | 0 |
FER | FER | P16591 | Tyrosine-protein kinase Fer | chr5 | GO:0002699 | Not Cancer Driver | No | 114 | 0.139 | 145 | 21 | 0.145 | 0 |
FES | FES | P07332 | Tyrosine-protein kinase Fes/Fps | chr15 | GO:0002699 | Census | Yes | 103 | 0.125 | 245 | 34 | 0.139 | 0 |
FFAR2 | FFAR2 | O15552 | Free fatty acid receptor 2 | chr19 | GO:0002699 | Not Cancer Driver | No | 49 | 0.148 | 32 | 7 | 0.219 | 0 |
FFAR3 | FFAR3 | O14843 | Free fatty acid receptor 3 | chr19 | GO:0002699 | Not Cancer Driver | No | 78 | 0.225 | 29 | 6 | 0.207 | 0 |
FGR_ENST00000374004 | FGR | P09769 | Tyrosine-protein kinase Fgr | chr1 | GO:0002699 | Not Cancer Driver | No | 85 | 0.161 | 52 | 8 | 0.154 | 0 |
FOXF1 | FOXF1 | Q12946 | Forkhead box protein F1 | chr16 | GO:0002699 | Not Cancer Driver | No | 56 | 0.148 | 194 | 20 | 0.103 | 20 |
FOXP3 | FOXP3 | Q9BZS1 | Forkhead box protein P3 | chrX | GO:0002699 | Not Cancer Driver | No | 38 | 0.088 | 186 | 16 | 0.086 | 10 |
FZD5 | FZD5 | Q13467 | Frizzled-5 | chr2 | GO:0002699 | Not Cancer Driver | No | 45 | 0.077 | 58 | 4 | 0.069 | 0 |
GAB2 | GAB2 | Q9UQC2 | GRB2-associated-binding protein 2 | chr11 | GO:0002699 | Not Cancer Driver | No | 85 | 0.126 | 537 | 73 | 0.136 | 0 |
GATA1 | GATA1 | P15976 | Erythroid transcription factor | chrX | GO:0002699 | Census, Compendium | Yes | 68 | 0.165 | 242 | 41 | 0.169 | 5 |
GATA2_ENST00000487848 | GATA2 | P23769 | Endothelial transcription factor GATA-2 | chr3 | GO:0002699 | Census, Compendium | Yes | 72 | 0.15 | 370 | 49 | 0.132 | 6 |
GATA3_ENST00000346208 | GATA3 | P23771 | Trans-acting T-cell-specific transcription factor GATA-3 | chr10 | GO:0002699 | Census, Compendium | Yes | 111 | 0.251 | 364 | 87 | 0.239 | 2 |
GPRC5B_ENST00000569479 | GPRC5B | Q9NZH0 | G-protein coupled receptor family C group 5 member B | chr16 | GO:0002699 | Not Cancer Driver | No | 82 | 0.203 | 75 | 19 | 0.253 | 0 |
HK1_ENST00000359426 | HK1 | P19367 | Hexokinase-1 | chr10 | GO:0002699 | Not Cancer Driver | No | 127 | 0.138 | 75 | 16 | 0.213 | 6 |
HLA-A_ENST00000376809 | HLA-A | P04439 | HLA class I histocompatibility antigen, A alpha chain | chr6 | GO:0002699 | Census, Compendium | Yes | 128 | 0.351 | 125 | 60 | 0.48 | 0 |
HLA-B | HLA-B | P01889 | HLA class I histocompatibility antigen, B alpha chain | chr6 | GO:0002699 | Compendium | Yes | 78 | 0.215 | 169 | 34 | 0.201 | 0 |
HLA-DMB | HLA-DMB | P28068 | HLA class II histocompatibility antigen, DM beta chain | chr6 | GO:0002699 | Not Cancer Driver | No | 41 | 0.156 | 41 | 9 | 0.22 | 0 |
HLA-DRA | HLA-DRA | P01903 | HLA class II histocompatibility antigen, DR alpha chain | chr6 | GO:0002699 | Not Cancer Driver | No | 52 | 0.205 | 12 | 1 | 0.083 | 0 |
HLA-DRB1 | HLA-DRB1 | P01911 | HLA class II histocompatibility antigen, DRB1 beta chain | chr6 | GO:0002699 | Not Cancer Driver | No | 48 | 0.18 | 12 | 1 | 0.083 | 0 |
HLA-E | HLA-E | P13747 | HLA class I histocompatibility antigen, alpha chain E | chr6 | GO:0002699 | Not Cancer Driver | No | 63 | 0.176 | 138 | 39 | 0.283 | 0 |
HLA-F_ENST00000376861 | HLA-F | P30511 | HLA class I histocompatibility antigen, alpha chain F | chr6 | GO:0002699 | Not Cancer Driver | No | 43 | 0.124 | 115 | 22 | 0.191 | 0 |
HLA-G_ENST00000360323 | HLA-G | P17693 | HLA class I histocompatibility antigen, alpha chain G | chr6 | GO:0002699 | Not Cancer Driver | No | 94 | 0.278 | 85 | 22 | 0.259 | 0 |
HLX | HLX | Q14774 | H2.0-like homeobox protein | chr1 | GO:0002699 | Not Cancer Driver | No | 107 | 0.219 | 412 | 98 | 0.238 | 0 |
HMCES_ENST00000502878 | HMCES | Q96FZ2 | Abasic site processing protein HMCES | chr3 | GO:0002699 | Not Cancer Driver | No | 37 | 0.105 | 131 | 16 | 0.122 | 0 |
HMOX1 | HMOX1 | P09601 | Heme oxygenase 1 | chr22 | GO:0002699 | Not Cancer Driver | No | 46 | 0.16 | 81 | 13 | 0.16 | 0 |
HPX | HPX | P02790 | Hemopexin | chr11 | GO:0002699 | Not Cancer Driver | No | 60 | 0.13 | 53 | 8 | 0.151 | 0 |
HSPD1 | HSPD1 | P10809 | 60 kDa heat shock protein, mitochondrial | chr2 | GO:0002699 | Not Cancer Driver | No | 61 | 0.106 | 82 | 6 | 0.073 | 2 |
IFNG | IFNG | P01579 | Interferon gamma | chr12 | GO:0002699 | Not Cancer Driver | No | 51 | 0.307 | 23 | 6 | 0.261 | 0 |
IL10 | IL10 | P22301 | Interleukin-10 | chr1 | GO:0002699 | Not Cancer Driver | No | 19 | 0.107 | 23 | 1 | 0.043 | 0 |
IL12B | IL12B | P29460 | Interleukin-12 subunit beta | chr5 | GO:0002699 | Not Cancer Driver | No | 48 | 0.146 | 42 | 2 | 0.048 | 0 |
IL12RB1_ENST00000593993 | IL12RB1 | P42701 | Interleukin-12 receptor subunit beta-1 | chr19 | GO:0002699 | Not Cancer Driver | No | 108 | 0.163 | 207 | 38 | 0.184 | 1 |
IL13 | IL13 | P35225 | Interleukin-13 | chr5 | GO:0002699 | Not Cancer Driver | No | 20 | 0.137 | 0 | 0 | 0.0 | 0 |
IL13RA2_ENST00000243213 | IL13RA2 | Q14627 | Interleukin-13 receptor subunit alpha-2 | chrX | GO:0002699 | Not Cancer Driver | No | 69 | 0.182 | 0 | 0 | 0.0 | 0 |
IL17A | IL17A | Q16552 | Interleukin-17A | chr6 | GO:0002699 | Not Cancer Driver | No | 52 | 0.335 | 56 | 21 | 0.375 | 0 |
IL17F | IL17F | Q96PD4 | Interleukin-17F | chr6 | GO:0002699 | Not Cancer Driver | No | 42 | 0.258 | 34 | 11 | 0.324 | 1 |
IL18 | IL18 | Q14116 | Interleukin-18 | chr11 | GO:0002699 | Not Cancer Driver | No | 19 | 0.098 | 16 | 3 | 0.188 | 0 |
IL18R1_ENST00000233957 | IL18R1 | Q13478 | Interleukin-18 receptor 1 | chr2 | GO:0002699 | Not Cancer Driver | No | 104 | 0.192 | 18 | 3 | 0.167 | 0 |
IL1B | IL1B | P01584 | Interleukin-1 beta | chr2 | GO:0002699 | Not Cancer Driver | No | 39 | 0.145 | 16 | 3 | 0.188 | 0 |
IL1R1 | IL1R1 | P14778 | Interleukin-1 receptor type 1 | chr2 | GO:0002699 | Not Cancer Driver | No | 77 | 0.135 | 59 | 8 | 0.136 | 0 |
IL2 | IL2 | P60568 | Interleukin-2 | chr4 | GO:0002699 | Census | Yes | 24 | 0.157 | 6 | 1 | 0.167 | 0 |
IL23A | IL23A | Q9NPF7 | Interleukin-23 subunit alpha | chr12 | GO:0002699 | Not Cancer Driver | No | 15 | 0.079 | 42 | 3 | 0.071 | 0 |
IL23R | IL23R | Q5VWK5 | Interleukin-23 receptor | chr1 | GO:0002699 | Not Cancer Driver | No | 70 | 0.111 | 117 | 19 | 0.162 | 0 |
IL4 | IL4 | P05112 | Interleukin-4 | chr5 | GO:0002699 | Not Cancer Driver | No | 18 | 0.118 | 0 | 0 | 0.0 | 0 |
IL4R_ENST00000543915 | IL4R | P24394 | Interleukin-4 receptor subunit alpha | chr16 | GO:0002699 | Not Cancer Driver | No | 133 | 0.161 | 420 | 64 | 0.152 | 0 |
IL6 | IL6 | P05231 | Interleukin-6 | chr7 | GO:0002699 | Not Cancer Driver | No | 35 | 0.165 | 58 | 7 | 0.121 | 0 |
INAVA_ENST00000367342 | INAVA | Q3KP66 | Innate immunity activator protein | chr1 | GO:0002699 | Not Cancer Driver | No | 112 | 0.169 | 553 | 98 | 0.177 | 1 |
ITGAM_ENST00000287497 | ITGAM | P11215 | Integrin alpha-M | chr16 | GO:0002699 | Not Cancer Driver | No | 191 | 0.166 | 133 | 12 | 0.09 | 0 |
ITGB2_ENST00000355153 | ITGB2 | P05107 | Integrin beta-2 | chr21 | GO:0002699 | Not Cancer Driver | No | 147 | 0.191 | 59 | 9 | 0.153 | 15 |
KIT | KIT | P10721 | Mast/stem cell growth factor receptor Kit | chr4 | GO:0002699 | Census, Compendium | Yes | 226 | 0.232 | 83 | 33 | 0.398 | 21 |
KLK3 | KLK3 | P07288 | Prostate-specific antigen | chr19 | GO:0002699 | Not Cancer Driver | No | 68 | 0.261 | 6 | 1 | 0.167 | 0 |
KLK5_ENST00000593428 | KLK5 | Q9Y337 | Kallikrein-5 | chr19 | GO:0002699 | Not Cancer Driver | No | 69 | 0.235 | 75 | 16 | 0.213 | 0 |
KLK7 | KLK7 | P49862 | Kallikrein-7 | chr19 | GO:0002699 | Not Cancer Driver | No | 43 | 0.17 | 38 | 8 | 0.211 | 0 |
KLRC2 | KLRC2 | P26717 | NKG2-C type II integral membrane protein | chr12 | GO:0002699 | Not Cancer Driver | No | 55 | 0.238 | 45 | 17 | 0.378 | 0 |
KMT5B_ENST00000615954 | KMT5B | Q4FZB7 | Histone-lysine N-methyltransferase KMT5B | chr11 | GO:0002699 | Not Cancer Driver | No | 147 | 0.166 | 659 | 113 | 0.171 | 0 |
KMT5C | KMT5C | Q86Y97 | Histone-lysine N-methyltransferase KMT5C | chr19 | GO:0002699 | Not Cancer Driver | No | 37 | 0.08 | 142 | 9 | 0.063 | 0 |
LACC1 | LACC1 | Q8IV20 | Purine nucleoside phosphorylase LACC1 | chr13 | GO:0002699 | Not Cancer Driver | No | 50 | 0.116 | 4 | 0 | 0.0 | 1 |
LAMP1 | LAMP1 | P11279 | Lysosome-associated membrane glycoprotein 1 | chr13 | GO:0002699 | Not Cancer Driver | No | 47 | 0.113 | 93 | 10 | 0.108 | 0 |
LAPTM5 | LAPTM5 | Q13571 | Lysosomal-associated transmembrane protein 5 | chr1 | GO:0002699 | Not Cancer Driver | No | 46 | 0.176 | 16 | 6 | 0.375 | 0 |
LBP | LBP | P18428 | Lipopolysaccharide-binding protein | chr20 | GO:0002699 | Not Cancer Driver | No | 84 | 0.175 | 6 | 0 | 0.0 | 0 |
LGALS9 | LGALS9 | O00182 | Galectin-9 | chr17 | GO:0002699 | Not Cancer Driver | No | 54 | 0.152 | 65 | 16 | 0.246 | 0 |
LILRB1_ENST00000396331 | LILRB1 | Q8NHL6 | Leukocyte immunoglobulin-like receptor subfamily B member 1 | chr19 | GO:0002699 | Not Cancer Driver | No | 203 | 0.312 | 291 | 97 | 0.333 | 0 |
LTA | LTA | P01374 | Lymphotoxin-alpha | chr6 | GO:0002699 | Not Cancer Driver | No | 37 | 0.18 | 20 | 5 | 0.25 | 0 |
LYN | LYN | P07948 | Tyrosine-protein kinase Lyn | chr8 | GO:0002699 | Census | Yes | 95 | 0.186 | 84 | 12 | 0.143 | 0 |
MAD2L2 | MAD2L2 | Q9UI95 | Mitotic spindle assembly checkpoint protein MAD2B | chr1 | GO:0002699 | Not Cancer Driver | No | 22 | 0.104 | 0 | 0 | 0.0 | 1 |
MALT1 | MALT1 | Q9UDY8 | Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | chr18 | GO:0002699 | Census, Compendium | Yes | 75 | 0.091 | 139 | 12 | 0.086 | 1 |
MAP3K7 | MAP3K7 | O43318 | Mitogen-activated protein kinase kinase kinase 7 | chr6 | GO:0002699 | Not Cancer Driver | No | 104 | 0.172 | 333 | 66 | 0.198 | 6 |
MAVS | MAVS | Q7Z434 | Mitochondrial antiviral-signaling protein | chr20 | GO:0002699 | Not Cancer Driver | No | 70 | 0.13 | 411 | 58 | 0.141 | 0 |
MBL2 | MBL2 | P11226 | Mannose-binding protein C | chr10 | GO:0002699 | Not Cancer Driver | No | 63 | 0.254 | 122 | 32 | 0.262 | 0 |
MIF | MIF | P14174 | Macrophage migration inhibitory factor | chr22 | GO:0002699 | Not Cancer Driver | No | 4 | 0.035 | 0 | 0 | 0.0 | 0 |
MLH1 | MLH1 | P40692 | DNA mismatch repair protein Mlh1 | chr3 | GO:0002699 | Census | Yes | 92 | 0.122 | 208 | 22 | 0.106 | 85 |
MR1 | MR1 | Q95460 | Major histocompatibility complex class I-related gene protein | chr1 | GO:0002699 | Not Cancer Driver | No | 60 | 0.176 | 33 | 7 | 0.212 | 0 |
MSH2 | MSH2 | P43246 | DNA mismatch repair protein Msh2 | chr2 | GO:0002699 | Census | Yes | 92 | 0.099 | 37 | 4 | 0.108 | 70 |
MYB_ENST00000367814 | MYB | P10242 | Transcriptional activator Myb | chr6 | GO:0002699 | Census | Yes | 82 | 0.128 | 528 | 69 | 0.131 | 0 |
MYO18A | MYO18A | Q92614 | Unconventional myosin-XVIIIa | chr17 | GO:0002699 | Not Cancer Driver | No | 268 | 0.13 | 1237 | 176 | 0.142 | 0 |
NECTIN2 | NECTIN2 | Q92692 | Nectin-2 | chr19 | GO:0002699 | Not Cancer Driver | No | 63 | 0.117 | 296 | 29 | 0.098 | 0 |
NFKBID | NFKBID | Q8NI38 | NF-kappa-B inhibitor delta | chr19 | GO:0002699 | Not Cancer Driver | No | 47 | 0.15 | 124 | 20 | 0.161 | 0 |
NFKBIZ | NFKBIZ | Q9BYH8 | NF-kappa-B inhibitor zeta | chr3 | GO:0002699 | Not Cancer Driver | No | 96 | 0.134 | 443 | 53 | 0.12 | 0 |
NLRP3_ENST00000391828 | NLRP3 | Q96P20 | NACHT, LRR and PYD domains-containing protein 3 | chr1 | GO:0002699 | Not Cancer Driver | No | 339 | 0.327 | 64 | 33 | 0.516 | 37 |
NOD2 | NOD2 | Q9HC29 | Nucleotide-binding oligomerization domain-containing protein 2 | chr16 | GO:0002699 | Not Cancer Driver | No | 169 | 0.163 | 40 | 4 | 0.1 | 15 |
NOS2 | NOS2 | P35228 | Nitric oxide synthase, inducible | chr17 | GO:0002699 | Not Cancer Driver | No | 207 | 0.18 | 201 | 33 | 0.164 | 0 |
NR4A3_ENST00000395097 | NR4A3 | Q92570 | Nuclear receptor subfamily 4 group A member 3 | chr9 | GO:0002699 | Census | Yes | 83 | 0.133 | 298 | 37 | 0.124 | 0 |
NSD2_ENST00000382892 | NSD2 | O96028 | Histone-lysine N-methyltransferase NSD2 | chr4 | GO:0002699 | Census, Compendium | Yes | 191 | 0.14 | 552 | 76 | 0.138 | 0 |
P2RX7 | P2RX7 | Q99572 | P2X purinoceptor 7 | chr12 | GO:0002699 | Not Cancer Driver | No | 51 | 0.086 | 14 | 2 | 0.143 | 0 |
PAXIP1 | PAXIP1 | Q6ZW49 | PAX-interacting protein 1 | chr7 | GO:0002699 | Not Cancer Driver | No | 120 | 0.112 | 461 | 39 | 0.085 | 0 |
PCK1 | PCK1 | P35558 | Phosphoenolpyruvate carboxykinase, cytosolic [GTP] | chr20 | GO:0002699 | Not Cancer Driver | No | 142 | 0.228 | 110 | 28 | 0.255 | 1 |
PDPK1 | PDPK1 | O15530 | 3-phosphoinositide-dependent protein kinase 1 | chr16 | GO:0002699 | Not Cancer Driver | No | 33 | 0.059 | 121 | 12 | 0.099 | 0 |
PGC | PGC | P20142 | Gastricsin | chr6 | GO:0002699 | Not Cancer Driver | No | 60 | 0.155 | 20 | 1 | 0.05 | 0 |
PHB_ENST00000300408 | PHB1 | P35232 | Prohibitin 1 | chr17 | GO:0002699 | Not Cancer Driver | No | 37 | 0.136 | 4 | 1 | 0.25 | 0 |
PLA2G3 | PLA2G3 | Q9NZ20 | Group 3 secretory phospholipase A2 | chr22 | GO:0002699 | Not Cancer Driver | No | 115 | 0.226 | 175 | 39 | 0.223 | 0 |
PLA2G5 | PLA2G5 | P39877 | Phospholipase A2 group V | chr1 | GO:0002699 | Not Cancer Driver | No | 24 | 0.174 | 0 | 0 | 0.0 | 2 |
PLCG2 | PLCG2 | P16885 | 1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase gamma-2 | chr16 | GO:0002699 | Not Cancer Driver | No | 248 | 0.196 | 142 | 30 | 0.211 | 1 |
PRKCZ | PRKCZ | Q05513 | Protein kinase C zeta type | chr1 | GO:0002699 | Not Cancer Driver | No | 70 | 0.118 | 116 | 11 | 0.095 | 0 |
PTAFR_ENST00000305392 | PTAFR | P25105 | Platelet-activating factor receptor | chr1 | GO:0002699 | Not Cancer Driver | No | 42 | 0.123 | 0 | 0 | 0.0 | 0 |
PTPN22 | PTPN22 | Q9Y2R2 | Tyrosine-protein phosphatase non-receptor type 22 | chr1 | GO:0002699 | Not Cancer Driver | No | 141 | 0.175 | 364 | 62 | 0.17 | 4 |
PTPN6_ENST00000318974 | PTPN6 | P29350 | Tyrosine-protein phosphatase non-receptor type 6 | chr12 | GO:0002699 | Census, Compendium | Yes | 73 | 0.123 | 192 | 25 | 0.13 | 0 |
PTPRC | PTPRC | P08575 | Receptor-type tyrosine-protein phosphatase C | chr1 | GO:0002699 | Census, Compendium | Yes | 315 | 0.241 | 462 | 107 | 0.232 | 0 |
PTPRJ | PTPRJ | Q12913 | Receptor-type tyrosine-protein phosphatase eta | chr11 | GO:0002699 | Not Cancer Driver | No | 184 | 0.138 | 401 | 61 | 0.152 | 0 |
PVR | PVR | P15151 | Poliovirus receptor | chr19 | GO:0002699 | Not Cancer Driver | No | 39 | 0.094 | 120 | 19 | 0.158 | 0 |
RABGEF1_ENST00000284957 | RABGEF1 | Q9UJ41 | Rab5 GDP/GTP exchange factor | chr7 | GO:0002699 | Not Cancer Driver | No | 73 | 0.149 | 175 | 35 | 0.2 | 0 |
RAC2 | RAC2 | P15153 | Ras-related C3 botulinum toxin substrate 2 | chr22 | GO:0002699 | Not Cancer Driver | No | 31 | 0.161 | 0 | 0 | 0.0 | 2 |
RAET1G | RAET1G | Q6H3X3 | UL-16 binding protein 5 | chr6 | GO:0002699 | Not Cancer Driver | No | 41 | 0.123 | 62 | 10 | 0.161 | 0 |
RARA | RARA | P10276 | Retinoic acid receptor alpha | chr17 | GO:0002699 | Census, Compendium | Yes | 70 | 0.152 | 167 | 14 | 0.084 | 0 |
RIF1 | RIF1 | Q5UIP0 | Telomere-associated protein RIF1 | chr2 | GO:0002699 | Not Cancer Driver | No | 287 | 0.116 | 1355 | 164 | 0.121 | 0 |
RIPK2 | RIPK2 | O43353 | Receptor-interacting serine/threonine-protein kinase 2 | chr8 | GO:0002699 | Not Cancer Driver | No | 63 | 0.117 | 143 | 20 | 0.14 | 0 |
RPS19_ENST00000600467 | RPS19 | P39019 | 40S ribosomal protein S19 | chr19 | GO:0002699 | Not Cancer Driver | No | 15 | 0.103 | 61 | 3 | 0.049 | 23 |
RSAD2 | RSAD2 | Q8WXG1 | Radical S-adenosyl methionine domain-containing protein 2 | chr2 | GO:0002699 | Not Cancer Driver | No | 68 | 0.188 | 22 | 1 | 0.045 | 0 |
SASH3 | SASH3 | O75995 | SAM and SH3 domain-containing protein 3 | chrX | GO:0002699 | Not Cancer Driver | No | 59 | 0.155 | 327 | 49 | 0.15 | 0 |
SCIMP | SCIMP | Q6UWF3 | SLP adapter and CSK-interacting membrane protein | chr17 | GO:0002699 | Not Cancer Driver | No | 10 | 0.069 | 73 | 9 | 0.123 | 0 |
SEMA7A | SEMA7A | O75326 | Semaphorin-7A | chr15 | GO:0002699 | Not Cancer Driver | No | 81 | 0.122 | 150 | 21 | 0.14 | 0 |
SH2D1B | SH2D1B | O14796 | SH2 domain-containing protein 1B | chr1 | GO:0002699 | Not Cancer Driver | No | 34 | 0.258 | 0 | 0 | 0.0 | 0 |
SHLD1 | SHLD1 | Q8IYI0 | Shieldin complex subunit 1 | chr20 | GO:0002699 | Not Cancer Driver | No | 30 | 0.146 | 116 | 20 | 0.172 | 0 |
SHLD2_ENST00000298784 | SHLD2 | Q86V20 | Shieldin complex subunit 2 | chr10 | GO:0002699 | Not Cancer Driver | No | 84 | 0.101 | 157 | 14 | 0.089 | 0 |
SHLD3 | SHLD3 | Q6ZNX1 | Shieldin complex subunit 3 | chr5 | GO:0002699 | Not Cancer Driver | No | 3 | 0.012 | 81 | 1 | 0.012 | 0 |
SIRT1 | SIRT1 | Q96EB6 | NAD-dependent protein deacetylase sirtuin-1 | chr10 | GO:0002699 | Not Cancer Driver | No | 70 | 0.094 | 435 | 31 | 0.071 | 0 |
SLAMF1_ENST00000302035 | SLAMF1 | Q13291 | Signaling lymphocytic activation molecule | chr1 | GO:0002699 | Not Cancer Driver | No | 82 | 0.245 | 64 | 10 | 0.156 | 0 |
SLC22A13 | SLC22A13 | Q9Y226 | Solute carrier family 22 member 13 | chr3 | GO:0002699 | Not Cancer Driver | No | 55 | 0.1 | 32 | 3 | 0.094 | 0 |
SLC7A5 | SLC7A5 | Q01650 | Large neutral amino acids transporter small subunit 1 | chr16 | GO:0002699 | Not Cancer Driver | No | 62 | 0.122 | 35 | 1 | 0.029 | 0 |
SNX4 | SNX4 | O95219 | Sorting nexin-4 | chr3 | GO:0002699 | Not Cancer Driver | No | 31 | 0.069 | 101 | 5 | 0.05 | 0 |
SOCS5 | SOCS5 | O75159 | Suppressor of cytokine signaling 5 | chr2 | GO:0002699 | Not Cancer Driver | No | 84 | 0.157 | 297 | 46 | 0.155 | 0 |
SPHK2 | SPHK2 | Q9NRA0 | Sphingosine kinase 2 | chr19 | GO:0002699 | Not Cancer Driver | No | 82 | 0.125 | 293 | 39 | 0.133 | 0 |
SPI1_ENST00000378538 | SPI1 | P17947 | Transcription factor PU.1 | chr11 | GO:0002699 | Not Cancer Driver | No | 46 | 0.17 | 187 | 34 | 0.182 | 0 |
SPON2_ENST00000431380 | SPON2 | Q9BUD6 | Spondin-2 | chr4 | GO:0002699 | Not Cancer Driver | No | 36 | 0.109 | 73 | 4 | 0.055 | 0 |
STAP1_ENST00000396225 | STAP1 | Q9ULZ2 | Signal-transducing adaptor protein 1 | chr4 | GO:0002699 | Not Cancer Driver | No | 66 | 0.224 | 103 | 18 | 0.175 | 0 |
STAT6_ENST00000543873 | STAT6 | P42226 | Signal transducer and activator of transcription 6 | chr12 | GO:0002699 | Census, Compendium | Yes | 106 | 0.125 | 325 | 44 | 0.135 | 0 |
STX4 | STX4 | Q12846 | Syntaxin-4 | chr16 | GO:0002699 | Not Cancer Driver | No | 50 | 0.168 | 152 | 20 | 0.132 | 0 |
STX7 | STX7 | O15400 | Syntaxin-7 | chr6 | GO:0002699 | Not Cancer Driver | No | 29 | 0.111 | 164 | 14 | 0.085 | 0 |
STXBP1_ENST00000373299 | STXBP1 | P61764 | Syntaxin-binding protein 1 | chr9 | GO:0002699 | Not Cancer Driver | No | 97 | 0.163 | 111 | 23 | 0.207 | 18 |
STXBP2_ENST00000221283 | STXBP2 | Q15833 | Syntaxin-binding protein 2 | chr19 | GO:0002699 | Not Cancer Driver | No | 77 | 0.13 | 80 | 13 | 0.163 | 5 |
SYK_ENST00000375746 | SYK | P43405 | Tyrosine-protein kinase SYK | chr9 | GO:0002699 | Census | Yes | 96 | 0.151 | 131 | 27 | 0.206 | 5 |
TBX21 | TBX21 | Q9UL17 | T-box transcription factor TBX21 | chr17 | GO:0002699 | Not Cancer Driver | No | 70 | 0.131 | 348 | 50 | 0.144 | 0 |
TFRC_ENST00000392396 | TFRC | P02786 | Transferrin receptor protein 1 | chr3 | GO:0002699 | Census | Yes | 89 | 0.117 | 80 | 6 | 0.075 | 1 |
TGFB1 | TGFB1 | P01137 | Transforming growth factor beta-1 proprotein | chr19 | GO:0002699 | Not Cancer Driver | No | 41 | 0.105 | 41 | 4 | 0.098 | 10 |
TICAM1 | TICAM1 | Q8IUC6 | TIR domain-containing adapter molecule 1 | chr19 | GO:0002699 | Not Cancer Driver | No | 92 | 0.129 | 443 | 66 | 0.149 | 1 |
TLR4_ENST00000355622 | TLR4 | O00206 | Toll-like receptor 4 | chr9 | GO:0002699 | Not Cancer Driver | No | 292 | 0.348 | 0 | 0 | 0.0 | 0 |
TNF | TNF | P01375 | Tumor necrosis factor | chr6 | GO:0002699 | Not Cancer Driver | No | 24 | 0.103 | 45 | 3 | 0.067 | 0 |
TNFRSF14 | TNFRSF14 | Q92956 | Tumor necrosis factor receptor superfamily member 14 | chr1 | GO:0002699 | Census, Compendium | Yes | 33 | 0.117 | 54 | 8 | 0.148 | 0 |
TNFSF13 | TNFSF13 | O75888 | Tumor necrosis factor ligand superfamily member 13 | chr17 | GO:0002699 | Not Cancer Driver | No | 14 | 0.056 | 109 | 6 | 0.055 | 0 |
TNFSF4 | TNFSF4 | P23510 | Tumor necrosis factor ligand superfamily member 4 | chr1 | GO:0002699 | Not Cancer Driver | No | 28 | 0.153 | 1 | 0 | 0.0 | 0 |
TP53BP1_ENST00000263801 | TP53BP1 | Q12888 | TP53-binding protein 1 | chr15 | GO:0002699 | Not Cancer Driver | No | 227 | 0.115 | 1632 | 190 | 0.116 | 0 |
TRAF2 | TRAF2 | Q12933 | TNF receptor-associated factor 2 | chr9 | GO:0002699 | Not Cancer Driver | No | 63 | 0.126 | 4 | 1 | 0.25 | 0 |
TRAF6_ENST00000348124 | TRAF6 | Q9Y4K3 | TNF receptor-associated factor 6 | chr11 | GO:0002699 | Not Cancer Driver | No | 67 | 0.128 | 62 | 7 | 0.113 | 0 |
TREM2 | TREM2 | Q9NZC2 | Triggering receptor expressed on myeloid cells 2 | chr6 | GO:0002699 | Not Cancer Driver | No | 43 | 0.187 | 27 | 2 | 0.074 | 1 |
TRIM6_ENST00000278302 | TRIM6 | Q9C030 | Tripartite motif-containing protein 6 | chr11 | GO:0002699 | Not Cancer Driver | No | 86 | 0.176 | 47 | 15 | 0.319 | 0 |
TYROBP | TYROBP | O43914 | TYRO protein tyrosine kinase-binding protein | chr19 | GO:0002699 | Not Cancer Driver | No | 24 | 0.212 | 28 | 8 | 0.286 | 0 |
UNC13D | UNC13D | Q70J99 | Protein unc-13 homolog D | chr17 | GO:0002699 | Not Cancer Driver | No | 120 | 0.11 | 248 | 30 | 0.121 | 0 |
USP17L2 | USP17L2 | Q6R6M4 | Ubiquitin carboxyl-terminal hydrolase 17 | chr8 | GO:0002699 | Not Cancer Driver | No | 105 | 0.198 | 201 | 54 | 0.269 | 0 |
VAMP7_ENST00000286448 | VAMP7 | P51809 | Vesicle-associated membrane protein 7 | chrX | GO:0002699 | Not Cancer Driver | No | 38 | 0.173 | 4 | 1 | 0.25 | 0 |
VAMP8 | VAMP8 | Q9BV40 | Vesicle-associated membrane protein 8 | chr2 | GO:0002699 | Not Cancer Driver | No | 9 | 0.09 | 27 | 0 | 0.0 | 0 |
WNT5A_ENST00000474267 | WNT5A | P41221 | Protein Wnt-5a | chr3 | GO:0002699 | Not Cancer Driver | No | 66 | 0.174 | 0 | 0 | 0.0 | 2 |
XBP1 | XBP1 | P17861 | X-box-binding protein 1 | chr22 | GO:0002699 | Not Cancer Driver | No | 19 | 0.073 | 169 | 9 | 0.053 | 0 |
XCL1 | XCL1 | P47992 | Lymphotactin | chr1 | GO:0002699 | Not Cancer Driver | No | 28 | 0.246 | 35 | 11 | 0.314 | 0 |
ZBTB1 | ZBTB1 | Q9Y2K1 | Zinc finger and BTB domain-containing protein 1 | chr14 | GO:0002699 | Not Cancer Driver | No | 70 | 0.098 | 271 | 27 | 0.1 | 0 |
ZP3 | ZP3 | P21754 | Zona pellucida sperm-binding protein 3 | chr7 | GO:0002699 | Not Cancer Driver | No | 55 | 0.13 | 56 | 11 | 0.196 | 1 |